Ticker Symbol: BMRN
Biomarin Pharmaceutical Inc. - Registered Shares
$81.30 - 18-04-2025 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001048477
Company Profile
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for serious and life-threatening rare and ultra-rare genetic diseases. The Company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 105 Digital Dr
Website: www.biomarin.com
CEO: Jean-Jacques Bienaime
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $82.11
Change:
-$0.48
(
-0.58%)
Days Range: $82.08 - $83.33
Beta: 0.64
52wk. High: $117.77
52wk. Low: $80.53
Ytd. Change -21.24%
50 Day Moving Average: $87.87
200 Day Moving Average: $90.88
Shares Outstanding: 188174773
Valuation
Market Cap: 1.5T
PE Ratio: 156.61
EPS (TTM): 0.5243
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A